Tag: Biotech and Pharmaceuticals

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Food supply ‘not at risk’ after new Texas screwworm cases, USDA secretary says

Weight loss drug maker sinks 25% after new safety data spooks investors

As the largest World Cup ever kicks off, health officials are focused on more than Ebola

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Eli Lilly’s top dealmaker says don’t be surprised to see more M&A that pushes Lilly into new areas

Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update

A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China

Replimune to resubmit twice-rejected drug for approval after FDA shakeup

CVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plans